These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 16042727

  • 1. Detrusor myectomy: long-term results with a minimum follow-up of 2 years.
    Kumar SP, Abrams PH.
    BJU Int; 2005 Aug; 96(3):341-4. PubMed ID: 16042727
    [Abstract] [Full Text] [Related]

  • 2. Detrusor myectomy: long-term functional outcomes.
    Aslam MZ, Agarwal M.
    Int J Urol; 2012 Dec; 19(12):1099-102. PubMed ID: 22852876
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detrusor compliance changes after bladder neck sling without augmentation in children with neurogenic urinary incontinence.
    Snodgrass W, Barber T, Cost N.
    J Urol; 2010 Jun; 183(6):2361-6. PubMed ID: 20400137
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E, Dik P, Klijn AJ, van Gool JD, de Jong TP.
    Neurourol Urodyn; 2004 Jun; 23(7):685-8. PubMed ID: 15382196
    [Abstract] [Full Text] [Related]

  • 12. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.
    Schulte-Baukloh H, Knispel HH, Stolze T, Weiss C, Michael T, Miller K.
    Urology; 2005 Oct; 66(4):865-70; discussion 870. PubMed ID: 16230156
    [Abstract] [Full Text] [Related]

  • 13. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A, Mearini E, Del Zingaro M, Porena M.
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E.
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up.
    Swami KS, Feneley RC, Hammonds JC, Abrams P.
    Br J Urol; 1998 Jan; 81(1):68-72. PubMed ID: 9467479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.